NASDAQ: AVIRAtea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?
Insider buying vs selling
Have Atea Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrea Corcoran | Chief Financial Officer Executive Vice President Legal and Secretary | 2024-02-01 | 15,843 | $3.85 | $60.92kSell |
| Wayne Foster | EVP Chief Accounting Officer | 2024-02-01 | 12,477 | $3.84 | $47.90kSell |
| Janet Mj Hammond | Chief Development Officer | 2024-02-01 | 14,029 | $3.84 | $53.91kSell |
| Maria Arantxa Horga | Chief Medical Officer | 2024-02-01 | 15,870 | $3.84 | $60.96kSell |
| Jeanpierre Sommadossi | President CEO and Chairman | 2024-02-01 | 56,910 | $3.85 | $218.82kSell |
| John Vavricka | Chief Commercial Officer | 2024-02-01 | 11,819 | $3.84 | $45.42kSell |
AVIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AVIR insiders and whales buy or sell their stock.
AVIR Shareholders
What type of owners hold Atea Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 11.22% | 9,443,887 | $34.66M | Institution |
| Ecor1 Capital LLC | 8.31% | 6,995,861 | $25.67M | Institution |
| Cormorant Asset Management LP | 7.62% | 6,411,355 | $23.53M | Insider |
| Jeanpierre Sommadossi | 7.18% | 6,041,557 | $22.17M | Insider |
| Andrew A. F. Hack | 6.67% | 5,615,659 | $20.61M | Insider |
| Bml Capital Management LLC | 6.49% | 5,462,079 | $20.05M | Institution |
| Fmr LLC | 6.36% | 5,350,659 | $19.64M | Institution |
| Vanguard Group Inc | 5.47% | 4,599,710 | $16.88M | Institution |
| Tang Capital Management LLC | 4.84% | 4,076,741 | $14.96M | Institution |
| Bain Capital Life Sciences Investors LLC | 2.95% | 2,485,638 | $9.12M | Institution |
AVIR vs Biotech Stocks
Atea Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.